<DOC>
	<DOC>NCT00804206</DOC>
	<brief_summary>Compare the effect of an intravitreal injection of bevacizumab previous or posterior of panretinal laser photocoagulation (PRLP) with a pattern laser; to prevent and reduce diabetic macular edema (DME) in patients with proliferative diabetic retinopathy (PDR) with DME.</brief_summary>
	<brief_title>Comparison of the Effects of Bevacizumab Before vs After Pattern Panretinal Photocoagulation</brief_title>
	<detailed_description />
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<criteria>Patients with proliferative diabetic retinopathy patients with macular edema patients with previous treatments patients with ocular surgeries</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2008</verification_date>
	<keyword>Intravitreal injection of Bevacizumab</keyword>
	<keyword>Visual acuity</keyword>
	<keyword>central retinal thickness</keyword>
	<keyword>color studies, Farnsworth-Munsell</keyword>
	<keyword>electroretinogram studies</keyword>
</DOC>